Exemestane metabolites: Synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line-Reference-Cited by-同舟云学术

Exemestane metabolites: Synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line

Published:2014-11 Issue: Volume:87 Page:336-345
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Varela Carla L.,Amaral Cristina,Tavares da Silva Elisiário^ORCID,Lopes Andreia,Correia-da-Silva Georgina,Carvalho Rui A.,Costa Saul C.P.,Roleira Fernanda M.F.^ORCID,Teixeira Natércia

Funder

FEDER Funds

National Funds

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference36 articles.

1. Global patterns of cancer incidence and mortality rates and trends;Jemal;Cancer Epidemiol. Biomarkers Prev. Publ. Am. Assoc. Cancer Res. Cospons. Am. Soc. Prev. Oncol.,2010

2. Aromatase inhibitors–where are we now?;Miller;Br. J. Cancer,1996

3. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer;Jordan;Steroids,2007

4. Exemestane, a new steroidal aromatase inhibitor of clinical relevance;Lombardi;Biochim. Biophys. Acta,2002

5. Aromatase inhibitors: structural features and biochemical characterization;Hong;Ann. N. Y. Acad. Sci.,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy;British Journal of Cancer;2024-02-10

2. Design, synthesis, biological activity evaluation and structure-activity relationships of new steroidal aromatase inhibitors. The case of C-ring and 7β substituted steroids;Bioorganic Chemistry;2023-02

3. An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER+) Breast Cancer: Effects on Sensitive and Resistant Cell Lines;Molecules;2023-01-12

4. Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules;Molecules;2021-12-15

5. Is it time to consider the Androgen receptor as a therapeutic target in breast cancer?;Anti-Cancer Agents in Medicinal Chemistry;2021-12-01